Herombopag

2

Review clinical trials related to Herombopag. Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Recruiting

A Clinical Study on the Efficacy and Safety of Herombopag in the Treatment of Senile Primary ITP

The objective of this study was to evaluate the efficacy and safety of Herombopag in the treatment of elderly patients with ITP.

Participants needed: 80
Trial details
Phase: Phase 2Age: 60+Biological sex: AllType: InterventionalSponsor: Institute of Hematology & Blood Diseases Hospital, ChinaUpdated: Mar 13, 2025Locations: 1
Eligibility criteria

Patients voluntarily participated in the study and signed informed consent; [+7]

Patients who did not respond to previous treatment with herombopag; [+15]

Status: Recruiting

Herombopag for Chemotherapy-induced Thrombocytopenia

To evaluate the efficacy and safety of Herombopag to treat chemotherapy-induced thrombocytopenia in Solid Tumors

Participants needed: 50
Trial details
Phase: Phase 2Age: 18+Biological sex: AllType: InterventionalSponsor: Institute of Hematology & Blood Diseases Hospital, ChinaUpdated: Feb 24, 2025Locations: 1
Eligibility criteria

Aged ≥18 years old, male or female; [+7]

Those with uncontrollable primary diseases of important organs, such as extensiv... [+14]